This inventor holds 1 USPTO granted patent. Top assignee: Merck Serono S. a.. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Jerome Wojcik: Innovator in Growth Hormone Therapy
Introduction
Jerome Wojcik is a notable inventor based in Divonne Les Bains, France. He has made significant contributions to the field of genetic research, particularly in the area of growth hormone therapy. His work focuses on improving treatment outcomes for patients with Growth Hormone Deficiency (GHD) and Turner Syndrome (TS).
Latest Patents
Wojcik holds a patent for "Genomic markers for prediction of long-term response to growth hormone (GH) therapy." This invention relates to the use of genetic markers to identify how patients with GHD or TS respond to growth hormone treatment. It also includes methods for treating these patients and kits for genotyping. He has 1 patent to his name.
Career Highlights
Jerome Wojcik is currently employed at Merck Serono S.A., a leading biopharmaceutical company. His role involves research and development in the field of endocrinology, where he applies his expertise to enhance therapeutic strategies for hormone-related conditions.
Collaborations
Wojcik has collaborated with several professionals in his field, including Pascal Croteau and John Raelson. These collaborations have contributed to the advancement of research in growth hormone therapies.
Conclusion
Jerome Wojcik's innovative work in genomic markers for growth hormone therapy exemplifies the intersection of genetics and medicine. His contributions are paving the way for more effective treatments for patients with hormonal deficiencies.